Thyroid hormones modulate uric acid metabolism in patients with recent onset subclinical hypothyroidism by improving insulin sensitivity

2019 ◽  
Vol 15 (1) ◽  
pp. 67-71 ◽  
Author(s):  
Giovambattista Desideri ◽  
Raffaella Bocale ◽  
Anna Maria D’Amore ◽  
Giulia Carnassale ◽  
Stefano Necozione ◽  
...  



1923 ◽  
Vol 55 (3) ◽  
pp. 373-384
Author(s):  
Howard B. Lewis ◽  
Ralph C. Corley
Keyword(s):  


1957 ◽  
Vol 227 (2) ◽  
pp. 653-668 ◽  
Author(s):  
Saul Green ◽  
Abraham Mazur
Keyword(s):  


1914 ◽  
Vol 19 (4) ◽  
pp. 473-485
Author(s):  
G.W. Raiziss ◽  
H. Dubin ◽  
A.I. Ringer
Keyword(s):  


2014 ◽  
Vol 28 (3) ◽  
pp. 298-304 ◽  
Author(s):  
Petter Bjornstad ◽  
Janet K. Snell-Bergeon ◽  
Kimberly McFann ◽  
R. Paul Wadwa ◽  
Marian Rewers ◽  
...  


2021 ◽  
Vol 16 ◽  
Author(s):  
Reihaneh Rezaee ◽  
Masoud Mohebbi ◽  
Mozhgan Afkhamizadeh ◽  
Mohammad Ali Yaghoubi ◽  
Mona Najaf Najafi ◽  
...  

Background and Objective: Subclinical hypothyroidism can potentially develop to overt hypothyroidism. Thyroid hormones have substantial roles in metabolism and glucose homeostasis and thus are closely related to determinant factors of metabolic syndromes, such as obesity and insulin resistance. Osteocalcin is considered a predictor of metabolic conditions in thyroid diseases. This study aimed to investigate the effect of levothyroxine vs. placebo on serum osteocalcin levels in patients with subclinical hypothyroidism. Methods: This randomized clinical trial was performed on 30 patients with subclinical hypothyroidism who were referred to the endocrine clinics of Ghaem and Imam Reza hospitals in Mashhad, Iran. After giving informed consent, patients were randomly divided into intervention (50 µg/day levothyroxine for 2 months) and control (placebo) groups. Serum levels of osteocalcin, thyroid hormones, lipid profile, insulin, and fasting glucose, as well as other clinical and anthropometric data, were measured at baseline and at the end of the study. SPSS was used to analyze the data and P<0.05 was considered significant. Results: Mean age in the intervention and control groups was 35.07 ± 9.94 and 31.30 ± 4.30, respectively (P=0.20). There was no significant difference between osteocalcin levels before and after the intervention in either of the groups (P=0.54). TSH level was significantly decreased in the levothyroxine group after the intervention (P<0.01). T4 level was significantly increased in the intervention group (P=0.02). Conclusion: Levothyroxine had no significant effect on increasing the levels of serum osteocalcin in patients with subclinical hypothyroidism. We have registered the trial in the Iranian registry of clinical trials (IRCT) with the registration code IRCT20171129037677N1.



1983 ◽  
pp. 155-172
Author(s):  
Edwin Mejías ◽  
Manuel Martínez-Maldonado
Keyword(s):  


1991 ◽  
Vol 67 (11) ◽  
pp. 1271-1281
Author(s):  
Naotoshi SATOH ◽  
Kenjiro KIKUCHI ◽  
Tohru HASEGAWA ◽  
Hiroaki KOMURA ◽  
Shin-ichiro SUZUKI ◽  
...  


2010 ◽  
Vol 49 (2) ◽  
pp. 89-94 ◽  
Author(s):  
Daijiro Uetake ◽  
Iwao Ohno ◽  
Kimiyoshi Ichida ◽  
Yuichiro Yamaguchi ◽  
Hajime Saikawa ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document